We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
-15.77%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$203M
AUM Growth
-$44.8M
Cap. Flow
-$2.03M
Cap. Flow %
-1%
Top 10 Hldgs %
31.93%
Holding
969
New
16
Increased
165
Reduced
215
Closed
50

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$947K
2
MKSI icon
MKS Inc
MKSI
+$191K
3
WBD icon
Warner Bros
WBD
+$177K
4
VLO icon
Valero Energy
VLO
+$110K
5
DHR icon
Danaher
DHR
+$97K

Sector Composition

Rank Sector Weight
1 Technology 36.03%
2 Healthcare 14.37%
3 Consumer Staples 7.26%
4 Financials 7.26%
5 Industrials 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTNX icon
726
Nutanix
NTNX
$14.2B
$3K ﹤0.01%
200
PCG icon
727
PG&E
PCG
$47B
$3K ﹤0.01%
311
QGEN icon
728
Qiagen
QGEN
$8.55B
$3K ﹤0.01%
58
RELX icon
729
RELX
RELX
$57.4B
$3K ﹤0.01%
98
-47
-32% -$1.35K
RGLD icon
730
Royal Gold
RGLD
$16.9B
$3K ﹤0.01%
28
ROCK icon
731
Gibraltar Industries
ROCK
$1.32B
$3K ﹤0.01%
88
+9
+11% +$367
SPIB icon
732
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$3K ﹤0.01%
101
TPH
733
DELISTED
Tri Pointe Homes
TPH
$3K ﹤0.01%
173
VBK icon
734
Vanguard Small-Cap Growth ETF
VBK
$23.4B
$3K ﹤0.01%
14
VC icon
735
Visteon
VC
$2.67B
$3K ﹤0.01%
30
VONV icon
736
Vanguard Russell 1000 Value ETF
VONV
$20.2B
$3K ﹤0.01%
44
WTS icon
737
Watts Water Technologies
WTS
$11.5B
$3K ﹤0.01%
24
ONC
738
BeOne Medicines Ltd
ONC
$33.9B
$3K ﹤0.01%
17
-3
-15% -$469
MDRX
739
DELISTED
Veradigm Inc. Common Stock
MDRX
$3K ﹤0.01%
220
LHCG
740
DELISTED
LHC Group LLC
LHCG
$3K ﹤0.01%
19
TWTR
741
DELISTED
Twitter, Inc.
TWTR
$3K ﹤0.01%
76
-30
-28% -$1.29K
ADRE
742
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$3K ﹤0.01%
70
AFRM icon
743
Affirm
AFRM
$23.8B
$2K ﹤0.01%
100
ALNY icon
744
Alnylam Pharmaceuticals
ALNY
$35.9B
$2K ﹤0.01%
14
AMX icon
745
America Movil
AMX
$77.9B
$2K ﹤0.01%
119
-56
-32% -$1.15K
AON icon
746
Aon
AON
$76B
$2K ﹤0.01%
8
-7
-47% -$2.01K
APAM icon
747
Artisan Partners
APAM
$2.73B
$2K ﹤0.01%
60
+7
+13% +$255
AVNS icon
748
Avanos Medical
AVNS
$1.17B
$2K ﹤0.01%
60
BOTZ icon
749
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.2B
$2K ﹤0.01%
100
CAH icon
750
Cardinal Health
CAH
$52.9B
$2K ﹤0.01%
45
+1
+2% +$57

Similar funds

Front Row Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Front Row Advisors held 969 positions worth $203M, down 18% from $248M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Front Row Advisors's Q2 2022 filing shows 16 new, 165 increased, 215 reduced and 50 closed positions. Its largest new stake was Warner Bros: 9,533 shares worth $128K. The largest sale was Berkshire Hathaway Class A, an estimated $1.06M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Front Row Advisors's largest Q2 2022 buy was Warner Bros: 9,533 shares worth $128K.
  • Front Row Advisors added most to Berkshire Hathaway Class B in Q2 2022, an estimated $947K increase.
  • Front Row Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $481K.
  • Front Row Advisors fully exited Berkshire Hathaway Class A in Q2 2022, selling an estimated $1.06M.
  • Front Row Advisors's ten largest holdings make up 32% of its $203M portfolio in Q2 2022.
  • Front Row Advisors opened 16 new positions and closed 50 in Q2 2022.
  • Front Row Advisors's portfolio value fell 18% quarter-over-quarter to $203M.

Based on Front Row Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.